Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca's Scientific Advisory Board

April 07, 2022   |   April 2022 Bond Updates
SÖDERTÄLJE, Sweden, April 7, 2022 /PRNewswire/ -- Anocca, a biotechnology company using its precision biology platforms to engineer a broad portfolio of innovative T cell therapeutics, today announced the appointment of Dr. Michael Kalos to its Scientific Advisory Board (SAB). Dr. Kalos...

View more at: https://www.prnewswire.com:443/news-releases/renowned-immunotherapy-expert-dr-michael-kalos-joins-anoccas-scientific-advisory-board-301519316.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/